Pfizer To Settle Celebrex, Bextra Suits For $894M

Law360, New York (October 17, 2008, 12:00 AM EDT) -- Drugmaker Pfizer Inc. has agreed to pay $894 million to settle the bulk of product liability, consumer fraud and state attorney general lawsuits filed against it over anti-inflammatory drugs Celebrex and Bextra.

The pharmaceutical giant announced Friday it had reached agreements in principle to resolve substantially all of the cases, which started piling up across the U.S. after a ruling by the U.S. Food and Drug Administration in February 2005 that the drugs led to an increased risk of heart damage.

“We are pleased by the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.